Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.51 | 21.62 | 26.98 | 16.30 | 17.42 | 9.06 | 5.77 | 4.56 | 12.00 | 23.24 | 101.95 | 31.01 |
| Expenses | 18.47 | 21.33 | 26.44 | 16.29 | 16.94 | 8.92 | 6.38 | 4.39 | 12.22 | 24.61 | 108.79 | 30.96 |
| Operating Profit | 0.04 | 0.29 | 0.54 | 0.01 | 0.48 | 0.14 | -0.61 | 0.17 | -0.22 | -1.37 | -6.84 | 0.05 |
| OPM % | 0.22% | 1.34% | 2.00% | 0.06% | 2.76% | 1.55% | -10.57% | 3.73% | -1.83% | -5.90% | -6.71% | 0.16% |
| Other Income | 0.23 | -0.00 | -0.00 | 0.35 | -0.00 | 0.01 | 0.16 | 0.12 | 0.31 | 0.37 | 0.02 | 0.08 |
| Interest | 0.14 | 0.12 | 0.11 | 0.13 | 0.10 | 0.04 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | -0.00 | -0.00 | 0.01 | -0.00 | 0.01 | 0.01 | 0.01 | -0.00 | -0.00 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.13 | 0.17 | 0.42 | 0.23 | 0.37 | 0.10 | -0.46 | 0.29 | 0.09 | -1.01 | -6.83 | 0.12 |
| Tax % | 23.08% | 35.29% | 30.95% | 26.09% | 24.32% | 20.00% | -0.00% | 27.59% | 22.22% | -9.90% | -31.19% | -0.00% |
| Net Profit | 0.10 | 0.10 | 0.28 | 0.17 | 0.28 | 0.07 | -0.46 | 0.22 | 0.06 | -0.91 | -4.70 | 0.12 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | -0.01 | -0.05 | 0.00 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25 | 28 | 42 | 14 | 13 | 26 | 26 | 77 | 49 | 142 | 168 |
| Expenses | 24 | 24 | 35 | 14 | 17 | 27 | 27 | 75 | 49 | 151 | 177 |
| Operating Profit | 1 | 3 | 7 | 0 | -3 | -0 | -1 | 2 | 0 | -9 | -8 |
| OPM % | 4.7% | 12% | 16% | 1.0% | -24% | -0.7% | -4.3% | 2.6% | 0.0% | -6% | -5.0% |
| Other Income | -0 | 1 | 0 | 0 | 4 | 1 | 2 | -0 | 1 | 1 | 1 |
| Interest | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | -0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 4 | 6 | -1 | 0 | 0 | 1 | 1 | 0 | -8 | -8 |
| Tax % | 33% | 33% | 28% | -2% | 18% | 15% | 27% | 29% | 25% | -25% | |
| Net Profit | 1 | 2 | 4 | -1 | 0 | 0 | 0 | 1 | 0 | -6 | -5 |
| EPS in Rs | 0.94 | 0.06 | 0.08 | -0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | -0.06 | -0.06 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 60% | 77% | 357% | ||
| Compounded Profit Growth | % | % | % | -5036% | ||
| Stock Price CAGR | % | -30% | -69% | -59% | ||
| Return on Equity | 1% | -1% | -2% | -7% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 3 | 5 | 5 | 5 | 11 | 77 | 77 | 77 | 102 |
| Reserves | 1 | 3 | 18 | 17 | 17 | 12 | 6 | 7 | 7 | 1 |
| Borrowings | 3 | 4 | 5 | 8 | -0 | -0 | 10 | 5 | 0 | 0 |
| Other Liabilities | 5 | 8 | 5 | 4 | 13 | 13 | 6 | 17 | 7 | 6 |
| Total Liabilities | 8 | 18 | 32 | 33 | 35 | 35 | 99 | 106 | 91 | 109 |
| Fixed Assets | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 3 | 8 |
| Other Assets | 8 | 18 | 32 | 33 | 35 | 35 | 99 | 106 | 88 | 101 |
| Total Assets | 8 | 18 | 32 | 33 | 35 | 35 | 99 | 106 | 91 | 109 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -2 | -3 | -9 | -7 | 0 | -0 | -62 | 2 | -4 | -9 |
| Cash from Investing Activity | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 9 | -7 |
| Cash from Financing Activity | 1 | 3 | 10 | 5 | -0 | 1 | 62 | -2 | -5 | 25 |
| Net Cash Flow | -0 | -0 | 1 | -1 | 0 | 1 | -1 | -0 | 0 | 9 |
| Free Cash Flow | -2 | -3 | -9 | -7 | 0 | -0 | -62 | 2 | -4 | -9 |
| CFO/OP | -136% | -90% | -118% | -4,650% | -4% | -32% | 5,577% | 105% | -41,900% | 94% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59 | 182 | 164 | 318 | 460 | 224 | 287 | 160 | 201 | 50 |
| Inventory Days | 152 | 75 | 77 | 48 | 27 | 32 | 59 | 48 | 79 | 35 |
| Days Payable | 121 | 145 | 27 | 56 | 50 | 17 | 55 | 78 | 31 | 7 |
| Cash Conversion Cycle | 90 | 111 | 214 | 310 | 436 | 238 | 290 | 130 | 249 | 77 |
| Working Capital Days | 30 | 102 | 183 | 702 | 791 | 407 | 449 | 305 | 530 | 182 |
| ROCE % | 65% | 37% | 1% | 2% | 3% | 1% | 2% | 1% | -9% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 16.24% | 16.24% | 16.24% | 16.24% | 16.24% | 7.41% | 7.41% | 7.41% | 9.16% | 9.16% | 9.16% | 9.16% |
| FIIs | 0.00% | 0.00% | 1.09% | 1.20% | 0.20% | 0.00% | 0.57% | 0.57% | 0.43% | 0.43% | 0.43% | 0.43% |
| Public | 83.76% | 83.77% | 82.67% | 82.56% | 83.57% | 92.59% | 92.02% | 92.03% | 90.41% | 90.41% | 90.41% | 90.41% |
| No. of Shareholders | 20,001 | 24,475 | 45,013 | 52,517 | 97,370 | 1,60,311 | 1,66,517 | 1,65,797 | 1,65,636 | 1,62,955 | 1,60,259 | 1,58,442 |
Fundamentals
Market Cap₹ 38.6 Cr.
Current Price₹ 0.38
Book Value₹ 1.01
ROCE-8.99 %
ROE-6.74 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)357%
Compounded Profit Growth (TTM)-5036%
Standalone figures.
Valuation
Market capRs 37 Cr
Enterprise valueRs 27 Cr
Price to book0.36x
Price to sales0.22x
EV / sales0.16x
Earnings yield-14.86%
P/E, 3-year average459.79x
P/B, 3-year average2.44x
P/E, 5-year average939.73x
P/B, 5-year average4.63x
Profitability
Operating margin (excl. other income)-6.50%
Operating margin (incl. other income)-5.92%
EBITDA margin-4.52%
Pre-tax margin-4.54%
Net profit margin-3.23%
Net margin, latest quarter0.39%
ROE-6.74%
ROCE-8.99%
ROA-6.29%
ROE, 3-year average-1.77%
ROCE, 3-year average-2.08%
ROA, 3-year average-1.71%
ROE, 5-year average-0.53%
ROCE, 5-year average-0.34%
ROA, 5-year average-0.66%
ROIC (approx.)-6.12%
Tax rate25.33%
Other income / net worth0.80%
Growth
Sales growth (latest year)191.91%
Profit growth (latest year)-3800.00%
Sales CAGR, 3 years76.64%
Sales CAGR, 5 years60.43%
Sales growth QoQ-69.58%
Sales growth YoY (latest quarter)580.04%
Profit growth YoY (latest quarter)-45.45%
Per share
EPS (TTM)Rs -0.05
EPS (latest year)Rs -0.06
EPS (latest quarter)Rs 0.00
EPS, 3-year averageRs -0.02
EPS, 5-year averageRs 0.07
Book value per shareRs 1.01
Sales per shareRs 1.66
Cash flow per shareRs -0.09
Free cash flow per shareRs -0.09
Efficiency
Asset turnover1.31x
Fixed asset turnover2835.00x
Inventory turnover10.49x
Inventory days35 days
Debtor days50 days
Debtors turnover7.34x
Creditor days7 days
Cash conversion cycle77 days
Working capital days182 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 10 Cr
Net debtRs -9 Cr
Debt to equity0.00x
Owners' fund to total sources94.46%
Debt to assets0.16%
Cash flow
Cash from Operating Activity (latest year)Rs -9 Cr
Cash from Investing Activity (latest year)Rs -7 Cr
Cash from Financing Activity (latest year)Rs 25 Cr
Net Cash Flow (latest year)Rs 9 Cr
Free cash flow (latest year)Rs -9 Cr
FCFE (approx.: FCF + change in debt)Rs -9 Cr
Statement figures
Net sales (TTM)Rs 168 Cr
Net sales (latest year)Rs 142 Cr
Sales (latest quarter)Rs 31 Cr
Operating profit excl. other income (latest year)Rs -9 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs -8 Cr
PBDT (TTM)Rs -8 Cr
Profit before tax (TTM)Rs -8 Cr
Tax (latest year)Rs -2 Cr
Net profit (TTM)Rs -5 Cr
Net profit (latest year)Rs -6 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 138 Cr
Total expenditure (latest year)Rs 151 Cr
Total income (latest year)Rs 143 Cr
Share capitalRs 102 Cr
ReservesRs 1 Cr
Shareholders' fundsRs 103 Cr
Total assetsRs 109 Cr
Net blockRs 0 Cr
InvestmentsRs 8 Cr
ReceivablesRs 19 Cr
InventoryRs 13 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)101.53
Ownership
Promoter holding9.16% (+1.75 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.36 is the lowest in 8.1 years (median 4.42).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 541601 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -7.7% | -2.8% | -4.9 pts |
| 1 month | -7.7% | -6.8% | -0.9 pts |
| 3 months | -14.3% | -7.6% | -6.7 pts |
| 3 years | -97.2% | +14.2% | -111.4 pts |
| 5 years | -84.7% | +27.9% | -112.6 pts |
Red flags
F-score 3 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹31 Cr +580.0% vs Jun 2025.
Net profit ₹0 Cr -45.5%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Rajnish Wellness Ltd?
Rajnish Wellness Ltd (541601) has a market capitalisation of Rs 38.6 Cr. at the 2026-10-01 close.
What were Rajnish Wellness Ltd's latest quarterly results?
In the Jun 2026 quarter, Rajnish Wellness Ltd sales was Rs 31 Cr (+580.0% vs Jun 2025) and net profit was Rs 0 Cr.